Healthcare Discovery polygenic risk scores precision prevention 2026 showing genomic risk entering clinical care
| | |

The Polygenic Era: How Risk Scores Built From Millions of Genetic Variants Are Reshaping Preventive Medicine in 2026

For two decades after the Human Genome Project, the promise of personalized medicine outran the data. In 2026, that gap is finally closing. Polygenic risk scores built from millions of…

Cardiologist reviewing ECG and remote heart monitoring data with a patient wearing a cardiac patch monitor
| | |

The Power of Zero: How Coronary Artery Calcium Scoring Became Cardiology’s Most Underused Prevention Tool

Coronary artery calcium (CAC) scoring shows whether atherosclerosis is already in your coronary arteries. Inside the Agatston origin story, the MESA evidence base, the Power of Zero, the AI tools…

Phosphatidylcholine mitochondria aging research in longevity laboratory | Healthcare Discovery
| | |

Cracking the Undruggable Code: How Daraxonrasib Just Rewrote the Rules for Pancreatic Cancer Survival

A new KRAS-targeting oral drug called daraxonrasib has nearly doubled survival in metastatic pancreatic cancer, with median overall survival of 13.2 months versus 6.7 months on chemotherapy in the landmark…

AI emergency room diagnosis Harvard study 2026 | Healthcare Discovery
| |

AI Outdiagnoses Emergency Room Doctors in Landmark Harvard Study: What It Means for the Future of Medical Care

A peer-reviewed study published in Science finds OpenAI’s o1 model correctly diagnosed 67% of real emergency room cases, beating two attending physicians and triggering one of the most consequential debates…

Alzheimer's blood-brain barrier nanoparticle research | Healthcare Discovery
| | |

Narcolepsy’s Second Brain Target: UCLA Researchers Discover a 25-Year Blind Spot That Could Transform Diagnosis and Treatment

A Nature Communications study from UCLA found that severe narcolepsy destroys neurons in a second brain region previously overlooked, overturning a foundational assumption held for nearly 25 years and opening…

Immune cells clearing damaged mitochondria through mitophagy as urolithin A supports immune rejuvenation
| | |

Your Thymus Didn’t Retire: Two Nature Studies Show This Overlooked Organ Predicts 50% Lower Death Risk

Two papers published in Nature in March 2026 used AI-powered CT analysis across 27,000 adults to show that thymic health predicts 50% lower all-cause mortality, 63% lower cardiovascular death, and…

Pancreatic cancer clinical trial research 2026 | Healthcare Discovery
| | |

Multi-Cancer Early Detection in 2026: cfDNA Methylation, the NHS-Galleri Trial, and the Tests That Could Reshape Cancer Screening

A new generation of liquid biopsy tests is trying to do something cancer screening has never done before: catch fifty kinds of cancer from a single tube of blood, often…

Phosphatidylcholine mitochondria aging research in longevity laboratory | Healthcare Discovery
| | |

The First RAS Inhibitor to Beat Pancreatic Cancer: What Daraxonrasib’s Phase 3 Survival Data Means for Oncology

Revolution Medicines’ daraxonrasib achieved a median overall survival of 13.2 months versus 6.7 months for chemotherapy in previously treated metastatic pancreatic cancer, a 60 percent reduction in the risk of…

Healthcare Discovery MechanoAge breast cancer AI mechanical age risk showing cells measured in a microfluidic diagnostic platform
| | |

Your Cells Have a Mechanical Age, and AI Can Now Read It to Predict Breast Cancer Risk

A UC Berkeley and City of Hope team published a landmark AI platform called MechanoAge in Lancet’s eBioMedicine that measures the physical stress-response of individual breast cells to identify cancer…

Healthcare Discovery NLR blood test Alzheimer’s risk detection 2026 showing immune inflammation signals connected to brain health
| | |

Your Immune System Has Been Keeping Score: The Blood Test That Could Predict Alzheimer’s Risk Years in Advance

A landmark study of nearly 400,000 patients from NYU Langone and the Veterans Health Administration reveals that the neutrophil-to-lymphocyte ratio, a number on your routine blood panel, is significantly associated…